Barriers and strategies in guideline implementation a scoping review. Healthcare (Basel) 2016;4. S6-7. Stacey D, Hill S, McCaffery K, et al. Shared decision making inter- ventions: theoretical and empirical evidence with implications for health literacy. Stud Health Technol Inform. 2017;240:263 83. S6-8. Stacey D, Legare F, Lewis K, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;4:CD001431. S6-9. Cabana MD, Rand CS, Powe NR, et al. Why don t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458 65. S6-10. Pokharel Y, Tang F, Jones PG, et al. Adoption of the 2013 American College of Cardiology/American Heart Association cholesterol management guideline in cardiology practices nationwide. JAMA Cardiol. 2017;2:361 9. S6-11. Rodriguez F, Lin S, Maron DJ, et al. Use of high-intensity statins for patients with atherosclerotic cardiovascular disease in the Veterans Affairs Health System: practice impact of the new cholesterol guide- lines. Am Heart J. 2016;182:97 102. S6-12. Pokharel Y, Gosch K, Nambi V, et al. Practice-level variation in statin use among patients with diabetes: insights from the PINNACLE Registry. J Am Coll Cardiol. 2016;68:1368 9. S6-13. Hira RS, Cowart JB, Akeroyd JM, et al. Risk factor optimization and guideline-directed medical therapy in US veterans with peripheral arterial and ischemic cerebrovascular disease compared to veterans with coronary heart disease. Am J Cardiol. 2016;118:1144 9. S6-14. Viswanathan M, Golin CE, Jones CD, et al. Interventions to improve adherence to self-administered medications for chronic dis- eases in the United States: a systematic review. Ann Intern Med. 2012;157:785 95. S6-15. Slejko JF, Ho M, Anderson HD, et al. Adherence to statins in primary prevention: yearly adherence changes and outcomes. J Manag Care Pharm. 2014;20:51 7. S6-16. Zimolzak AJ, Spettell CM, Fernandes J, et al. 